Literature DB >> 31927552

The Key Role of VEGF in the Cross Talk between Pterygium and Dry Eye and Its Clinical Significance.

Chang Liu1, Yiyue Song1, Xiaoran Wang1, Zhaoguang Lai1, Chaoyang Li1, Pengxia Wan1, Nuo Xu1, Danping Huang1, Yizhi Liu2, Zhichong Wang1.   

Abstract

PURPOSE: To examine whether dry eye severity is a risk factor for pterygium activity and whether vascular endothelial growth factor (VEGF) is crucial in the cross talk between pterygium and dry eye.
METHODS: A total of 103 patients with primary pterygium (Pteg) were included in the study group; they were divided into 2 groups according to the complication of dry eye (DE) (Pteg + DE group, Pteg - DE group). Further, 60 patients with just dry eye (DE group) and 60 normal individuals (normal) were included as 2 control groups. DE severity and pterygium activity were measured, and unstimulated tear samples and pterygium tissues were collected for cytokine detection.
RESULTS: (1) Tear detection: VEGF expression increased in the Pteg + DE group compared to the Pteg - DE, DE, and normal control groups; VEGF was especially increased in the active Pteg + DE group. VEGF concentration was positively correlated with pterygium activity. (2) Tissue detection: the mRNA expression of VEGF was upregulated in the active pterygium group.
CONCLUSIONS: Inflammation played an important role in the development of dry eye and pterygium. VEGF was the core molecule in the cross talk, which might explain the high incidence of the coexistence of these 2 diseases.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Cytokines; Dry eye; Inflammation; Pterygium; VEGF

Year:  2020        PMID: 31927552      PMCID: PMC7257259          DOI: 10.1159/000503636

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  47 in total

Review 1.  Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases.

Authors:  Nick Di Girolamo; Jeanie Chui; Minas T Coroneo; Denis Wakefield
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

2.  Cyclosporine A inhibits TGF-β2-induced myofibroblasts of primary cultured human pterygium fibroblasts.

Authors:  Sang Il Gum; Yeoun-Hee Kim; Jae-Chang Jung; Im Gyu Kim; Jun Seok Lee; Kyoo Won Lee; Young Jeung Park
Journal:  Biochem Biophys Res Commun       Date:  2016-12-02       Impact factor: 3.575

3.  Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells.

Authors:  N Dushku; M K John; G S Schultz; T W Reid
Journal:  Arch Ophthalmol       Date:  2001-05

4.  Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea.

Authors:  Zhi-Xin Yan; Yi Luo; Ning-Fei Liu
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

5.  Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.

Authors:  Kosuke Watari; Shintaro Nakao; Abbas Fotovati; Yuji Basaki; Fumihito Hosoi; Biborka Bereczky; Ryuichi Higuchi; Tomofumi Miyamoto; Michihiko Kuwano; Mayumi Ono
Journal:  Biochem Biophys Res Commun       Date:  2008-10-23       Impact factor: 3.575

6.  Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.

Authors:  Michael E Stern; Jianping Gao; Tammy A Schwalb; Mylinh Ngo; David D Tieu; Chi-Chao Chan; Brenda L Reis; Scott M Whitcup; Darby Thompson; Janine A Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

Review 7.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

8.  Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia.

Authors:  Ji Jin; Ming Guan; Jing Sima; Guoquan Gao; Mei Zhang; Zhuguo Liu; James Fant; Jian-xing Ma
Journal:  Cornea       Date:  2003-07       Impact factor: 2.651

Review 9.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

10.  Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye.

Authors:  Xiaodan Jiang; Huibin Lv; Weiqiang Qiu; Ziyuan Liu; Xuemin Li; Wei Wang
Journal:  Drug Des Devel Ther       Date:  2015-06-12       Impact factor: 4.162

View more
  5 in total

1.  Decreased retinal microvasculature densities in pterygium.

Authors:  Feng Wang; Qian-Min Ge; Hui-Ye Shu; Xu-Lin Liao; Rong-Bin Liang; Qiu-Yu Li; Li-Juan Zhang; Gui-Ping Gao; Yi Shao
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  Porcine Corneas Incubated at Low Humidity Present Characteristic Features Found in Dry Eye Disease.

Authors:  Alice Rocha Teixeira Netto; José Hurst; Karl-Ulrich Bartz-Schmidt; Sven Schnichels
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.

Authors:  Nuo Xu; Yi Cui; Jiaxing Dong; Li Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

4.  Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye.

Authors:  Lita Uthaithammarat; Ngamjit Kasetsuwan; Yuda Chongpison; Pimpetch Kasetsuwan; Usanee Reinprayoon; Pornjarim Nilyanimit; Yong Poovorawan
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

Review 5.  Pterygium-The Good, the Bad, and the Ugly.

Authors:  Sara I Van Acker; Bert Van den Bogerd; Michel Haagdorens; Vasiliki Siozopoulou; Sorcha Ní Dhubhghaill; Isabel Pintelon; Carina Koppen
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.